scholarly journals Comparing Clinical and Economic Outcomes Associated with Early Initiation of Combination Therapy of an Alpha Blocker and Dutasteride or Finasteride in Men with Benign Prostatic Hyperplasia in the United States

2016 ◽  
Vol 22 (10) ◽  
pp. 1204-1214 ◽  
Author(s):  
Maral DerSarkissian ◽  
Yongling Xiao ◽  
Mei Sheng Duh ◽  
Patrick Lefebvre ◽  
Andrine R. Swensen ◽  
...  
2017 ◽  
Vol 37 (1) ◽  
pp. 213-222 ◽  
Author(s):  
Jennifer T. Anger ◽  
Howard B. Goldman ◽  
Xuemei Luo ◽  
Martin O. Carlsson ◽  
Douglass Chapman ◽  
...  

1995 ◽  
pp. 205-206 ◽  
Author(s):  
William F. Gee ◽  
Logan Holtgrewe ◽  
Peter C. Albertsen ◽  
Mark S. Litwin ◽  
Michael J. Manyak ◽  
...  

Urology ◽  
1999 ◽  
Vol 53 (6) ◽  
pp. 1154-1159 ◽  
Author(s):  
Zhisen Xia ◽  
Rosebud O Roberts ◽  
David Schottenfeld ◽  
Michael M Lieber ◽  
Steven J Jacobsen

2016 ◽  
Vol 196 (1) ◽  
pp. 173-178 ◽  
Author(s):  
J. Quentin Clemens ◽  
Howard B. Goldman ◽  
Kelly H. Zou ◽  
Xuemei Luo ◽  
David Russell ◽  
...  

2021 ◽  
Vol 93 (4) ◽  
pp. 501-504
Author(s):  
Simone Brardi ◽  
Giuseppe Romano ◽  
Gabriele Cevenini

To the Editor, Benign Prostatic Hyperplasia (BPH) is one of the main causes of patients seeking urological counselling in Western countries. It has been estimated that nearly 70 percent of United States men between the ages of 60 and 69 years, and nearly 80 percent of men ≥ 70 years, have some degree of BPH [...].


Sign in / Sign up

Export Citation Format

Share Document